WOW !! Amendment 64 Poll: Colorado 'Set To Legalize Marijuana' On Election Day, PPP Survey Says
Posted: 11/05/2012 8:11 pm EST Updated: 11/05/2012 8:24 pm EST
With just hours before polling places open for Election Day, advocates for the legalization of marijuana in Colorado got some good news from Public Policy Polling about the popularity of Amendment 64, a ballot measure which seeks to regulate marijuana like alcohol, on Monday.
According to PPP, 52 percent of voters support Amendment 64 while only 44 percent are opposed to the measure leaving the state "set to legalize marijuana tomorrow," PPP's Tom Jensen writes about the results of their latest survey.
PPP also found that of the 1,096 likely Colorado voters, 56 percent favored the legalization of marijuana in general, while only 39 percent said the drug should remain illegal.
This is the highest percentage of support that PPP has found since they began surveying the issue of marijuana legalization. Back in September, PPP found 47 percent in favor of A64 and 38 percent against with 49 percent in favor of marijuana being legal, in general.
The highest support ever polled was from a June Rasmussen survey of 500 likely Colorado voters which showed 61 percent were in favor of legalizing marijuana if it is regulated the way that alcohol and cigarettes are currently regulated.
Voters in Colorado, Oregon and Washington are all considering measures that would effectively end marijuana prohibition in their respective states. Marijuana legalization has become an issue that defies the stereotypes of party lines, garnering the support of key progressives and conservatives in Colorado, Washington and Oregon. And although all three states have pot initiatives on their ballots, Colorado and Washington's pot ballot measures appear to be quite popular with voters, according to recent polling.
If marijuana is legalized in Colorado under Amendment 64 it would be taxed and regulated similar to alcohol and tobacco. It would give state and local governments the ability to control and tax the sale of small amounts of marijuana to adults age 21 and older. According to the Associated Press, analysts project that that tax revenue could generate somewhere between $5 million and $22 million a year in the state. An economist whose study was funded by a pro-pot group projects as much as a $60 million boost by 2017.
However, the big unknown still is if the federal government would allow a regulated marijuana market to take shape. Attorney General Eric Holder, who was a vocal opponent of California's legalization initiative in 2010 saying he would "vigorously enforce" federal marijuana prohibition, has continued to remain silent on the issue this year.
In September, Holder was urged by by nine former heads of the U.S. Drug Enforcement Administration to take a stand against marijuana legalization again. "To continue to remain silent conveys to the American public and the global community a tacit acceptance of these dangerous initiatives," the nine said in the letter to holder obtained by Reuters.
Earlier this month those same DEA drug warriors joined by former directors of the Office of National Drug Control Policy on a teleconference call to put additional pressure on Holder to speak out against Colorado's marijuana measure as well as similar initiatives on the ballot in Washington state and Oregon.
The drug warriors say that states that legalize marijuana for recreational use will trigger a "Constitutional showdown" with the federal government.
In a report published Sunday by NBC News, President Obama's former senior drug policy advisor said that if the marijuana initiatives pass, a war will be incited between the federal government and the states that pass them. "Once these sates actually try to implement these laws, we will sen an effort by the feds to shut it down," Sabet said.
But proponents of the legislation say they don't foresee federal agents interfering in states that have legalized cannabis, citing the federal government's silence on the issue this election cycle.
With Election Day less than 24 hours away, the DOJ has yet to formally announce its enforcement intentions regarding the ballot measures that, if passed, could end marijuana prohibition in each state. The clearest statement from the DOJ came from Deputy Attorney General James Cole, who said his office's stance on the issue would be "the same as it's always been." During a recent appearance on "60 Minutes" Cole elaborated, "We're going to take a look at whether or not there are dangers to the community from the sale of marijuana and we're going to go after those dangers," Reuters reported.
http://www.huffingtonpost.com/2012/11/05/amen...79908.html
WOW !! Amendment 64 Poll: Colorado 'Set To Legalize
Top 10 Most Recent News Articles
SVRN Taps Industry Vet Patrick O'Kain as COO
SVRN Aims for New Heights with a Savvy Hire If there’s one thing veteran market-watchers like myself know, it’s that leadership shifts can tell you more about a company’s guts than any press release. SVRN (NASDAQ: SVRN), a name with one foot firmly in the world of digital assets, just snagged Patrick O’Kain for their COO spot. They're not playing around, folks,...
Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections
Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...
Continue Reading
Sempra Shines with Robust Q3 2026 Financials
Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....
Continue Reading
Coastal Financial Faces Class Action Suit Over Securities
Securities Law Tangles: Coastal Financial Hits a Snag There's no dodging it—Coastal Financial Corporation's dogged by a class action lawsuit, and investors need to sit up and take notice. This kind of legal fracas can hit the stock price like a brick through a window, especially when alleged securities law violations crop up. DJS Law Group's got the reins on this one,...
Continue Reading
Grant Davis Joins Assembly Health as CXO
Shuffling Pieces in Healthcare Management Change is constant in healthcare management, folks, and it's all about finding the right puzzle pieces. That's what Assembly Health has done by welcoming Grant Davis as their new Chief Experience Officer (CXO). Yeah, you heard me right. It's not a CEO or a CFO, but the CXO role that's under the spotlight this time around, aiming...
Continue Reading
MAURE's Three-Year Mark: Crafting Home Elegance
Brooklyn's Gem: MAURE Turns Three Over in Brooklyn, there's a brand bubbling with style called MAURE. Now, we're talking three years strong, surviving the wild bout of the retail scene with a firm two feet planted in home and gifting. The Vision Turned Reality When Maureen Cavalieri, a hospitality veteran since 2009, first tossed this spark into the wind in 2023, it...
Continue Reading
Dizal Unveils Promising Data at ASH 2026
Pushing the Horizons in Hematological Research From the bustling streets of Shanghai to the global stage of the ASH 2026, Dizal has made its mark again. This year's presentations could very well shake up the hematological landscape, showcasing new possibilities for treatment strategies. Golidocitinib: A Game-Changer? Now here's a ticket we've been watching with some high...
Continue Reading
LOA Roofing's Growth Recap Taps Southstone's Backing
Pardon my skepticism, but when a roofing company names itself Life of Abundance, you know they're aiming to hit it big or at least make you think they're onto something special. LOA Roofing and Construction, holding its ground as a major player in the Central Texas market, set the stage for more ambitious growth. And they found themselves a dance partner in Southstone...
Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31
SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...
Continue Reading
Eli Lilly's Retatrutide Trials Signal Innovation
Unpacking Lilly's Latest Rheumatology Innovations Lilly's taking the stage at ACR Convergence 2026 with a potent arsenal of data that’s got folks buzzing. The company’s put the pedal to the metal on understanding the intertwining chords of obesity and rheumatologic conditions, and boy, are they not messing around. Retatrutide: A Triple Threat in the Making Headlining...
Continue ReadingTop 5 Most Recently Viewed Articles
SKYX Technologies Expands Market Presence with Insider Investments
SKYX Technologies' Corporate Developments SKYX Technologies, also known as SKYX (NASDAQ: SKYX), is taking significant strides in the smart technology sector. This dynamic company focuses on transforming homes and buildings into smarter, safer, and more advanced spaces. With a remarkable portfolio of over 97 issued and pending patents, SKYX aims to set a new standard in...
Continue Reading
Crinetics Pharmaceuticals Expands Workforce With Stock Options
Crinetics Pharmaceuticals Enhances Employee Incentives In a recent announcement, Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), based in San Diego, revealed a significant step in enhancing employee incentives and strengthening its workforce. On October 10, 2025, the company’s Compensation Committee authorized the granting of stock options and restricted stock units...
Continue Reading
Manulife Investment Management Earns Top Recognition in Sustainable Finance
Manulife Investment Management Recognized for Excellence In a significant acknowledgment of its leadership in sustainable finance, Manulife Investment Management (Manulife IM) has made it to the prestigious list of IPE Real Assets' Top 50 Natural Capital Managers. This recognition comes as the firm is gearing up for robust fundraising activities, with an exciting fund...
Continue Reading
Vaxart Reports Progress and Financial Performance for Q3 2025
Vaxart’s Business Progress and Financial Results Overview Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company, recently provided a significant update on its business and reported its financial outcomes for the third quarter of 2025. This latest communication showcases exciting developments in their oral recombinant vaccine platform, which is designed to...
Continue Reading
Madrigal Pharmaceuticals Marks Enrollment Milestone in NASH Study
Madrigal Pharmaceuticals Achieves Enrollment Milestone in NASH Study Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company dedicated to developing innovative therapies for liver diseases, has announced a significant milestone in their MAESTRO-NASH OUTCOMES clinical trial. This study evaluates the efficacy of resmetirom in patients diagnosed with...
Continue Reading